概括
在胰岛素依赖的糖尿病患者中,大脑血流 (CBF) 可能不稳定,观察到显著下降. 这些CBF波动可能会引起昏感,并导致糖尿病患者中风风险增加.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 心血管科学 心血管科学
背景情况:
- 胰岛素依赖性糖尿病 (IDDM) 与微血管并发症有关.
- 在糖尿病患者中,大脑血流 (CBF) 调节可能受损.
- 了解CBF变异对于管理糖尿病患者至关重要.
研究的目的:
- 为了研究胰岛素依赖糖尿病患者脑血流 (CBF) 的稳定性.
- 为了确定CBF变化是否与昏等症状相关.
- 探索CBF不稳定性对糖尿病大脑血管疾病病变的影响.
主要方法:
- 在23名依赖胰岛素的糖尿病患者中测量了脑血流 (CBF).
- 测量是在注射胰岛素和早餐之前和2-3小时后进行的.
- 分析CBF的变化,并记录患者报告的症状.
主要成果:
- 在23名糖尿病患者中,10名糖尿病患者中,CBF在白天显示出显著的变化.
- 在9名患者中观察到CBF的显著下降.
- 经历最大CBF下降的三名患者报告了即将发生的昏迷感,即使没有低血糖症.
结论:
- 与对照人群相比,胰岛素依赖糖尿病患者的脑血流 (CBF) 显著不稳定.
- 在糖尿病患者中,突然的CBF减少可能会导致昏的感觉,独立于低血糖症.
- 这些CBF波动与了解胰岛素依赖糖尿病中风险和病原性有关.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...


